We are live on ! Find out more
PCM

Parsifal Capital Management Portfolio holdings

AUM $849M
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
-0.67%
1 Year Est. Return
+28.52%
3 Year Est. Return
+104.05%
5 Year Est. Return
+98.76%
10 Year Est. Return
–
AUM
$849M
AUM Growth
-$370M
Cap. Flow
-$346M
Cap. Flow %
-40.76%
Top 10 Hldgs %
72.95%
Holding
24
New
6
Increased
1
Reduced
11
Closed
6

Top Buys

Rank Stock Value
1
COMP icon
Compass
COMP
+$125M
2
AKAM icon
Akamai
AKAM
+$47.7M
3
CZR icon
Caesars Entertainment
CZR
+$46M
4
JMIA
Jumia Technologies
JMIA
+$35.1M
5
TDC icon
Teradata
TDC
+$20.9M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$88M
2
GMED icon
Globus Medical
GMED
+$75M
3
VIAV icon
Viavi Solutions
VIAV
+$55.5M
4
UNH icon
UnitedHealth
UNH
+$49.6M
5
SN icon
SharkNinja
SN
+$47.6M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.98%
2 Technology 17.9%
3 Industrials 15.62%
4 Real Estate 10.26%
5 Materials 6.08%

No holdings matched the selected filter criteria.

Similar funds

BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
EPIMS
Evelyn Partners Investment Management Services London $850M AUM 20.89% 1-Year Est. Return
EBSAM
Eubel Brady & Suttman Asset Management Miamisburg, Ohio $845M AUM 12.93% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
BI
BBFIT Investments Singapore $842M AUM
QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return

Parsifal Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Parsifal Capital Management held 24 positions worth $849M, down 30% from $1.22B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Parsifal Capital Management withdrew a net $346M in Q1 2026, closing 6 positions and reducing 11 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $88M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

Against the trend, Parsifal Capital Management opened a new position in Compass worth $87.1M.

  • Parsifal Capital Management's largest Q1 2026 buy was Compass: 11,918,302 shares worth $87.1M.
  • Parsifal Capital Management added most to AvePoint in Q1 2026, an estimated $665K increase.
  • Parsifal Capital Management's biggest Q1 2026 reduction was Globus Medical, cutting an estimated $75M.
  • Parsifal Capital Management fully exited Teva Pharmaceuticals in Q1 2026, selling an estimated $88M.
  • Parsifal Capital Management's ten largest holdings make up 73% of its $849M portfolio in Q1 2026.
  • Parsifal Capital Management opened 6 new positions and closed 6 in Q1 2026.
  • Parsifal Capital Management's portfolio value fell 30% quarter-over-quarter to $849M.

Based on Parsifal Capital Management's 13F filing for Q1 2026, filed 15 May 2026.